High-yield points
- Not small adults: more often male, larger (more giant), and more often fusiform or dissecting, at the ICA terminus and in the posterior circulation .
- Giant aneurysms present with mass effect more than rupture .
- Fusiform and dissecting aneurysms need reconstruction (flow diversion) or occlusion and bypass. Flow diversion gives about 74–88% occlusion in children .
- Think infection (about 15%, endocarditis) and trauma (pseudoaneurysm). Treat ruptured infectious aneurysms early .
- Genetics: MOPDII (screen with MRA lifelong), vascular EDS (fragile arteries, endovascular risk) and PHACE (image with facial hemangioma) .
- Clip vs coil: similar outcomes, but coils recur more (about 13% vs 4%) .
- Image for life: 41% develop new or recurrent aneurysms over decades. Counsel against smoking .
Pediatric intracranial aneurysms are rare, accounting for less than 5% of all intracranial aneurysms . They are not small adult aneurysms. They are more often found in boys, are more often giant, fusiform or dissecting, and favor the ICA terminus and the posterior circulation. They are also more often infectious, traumatic or syndromic. Children also have decades of risk for recurrence and new aneurysms.
How pediatric aneurysms differ
- Sex and size:
- In a 30-year database (47 children vs 4,453 adults), pediatric aneurysms were more often in males and more often giant (25 mm or more), and most often at the MCA.
- SAH was more common in children: 53.2% vs 36.4% .
- Location:
- A literature review of 706 cases found a 1.8:1 male predominance, and the ICA bifurcation was the commonest site (26%).
- In the authors' own series, 42% were posterior circulation and 37% giant .
- Morphology: pediatric aneurysms are more commonly giant, fusiform or dissecting, treatment is more complex, and recurrence and new aneurysm formation are more frequent .
- Flow-diversion series: half the aneurysms were non-saccular, and 70% of patients were male .
Giant and fusiform aneurysms
- Giant aneurysms:
- Most often present with mass effect (56.6%), then rupture (30.4%).
- 41.3% are in the posterior circulation .
- Management is individualized, with microsurgery (52.2%) used more often than coiling (28.3%) in the literature .
- Fusiform and dissecting aneurysms: they have no neck to clip or coil.
- They often need parent-vessel reconstruction (flow diversion), parent-vessel occlusion, or bypass and trapping .
- Flow diversion in children:
- Multicenter (39 patients aged 21 or younger, 50 aneurysms): complete occlusion in 74%, mRS 0–2 in 83%, and 2 early deaths from rerupture of ruptured aneurysms. No occluded aneurysm recanalized .
- Meta-analysis (80 patients): final occlusion 88%, good outcome 92%, complications 3% and no device-related deaths .
Special causes
- Infectious (mycotic) aneurysms:
- About 15% of pediatric aneurysms. They are pseudoaneurysms, usually in the anterior circulation, and multiple in 15–25%. They often rupture .
- Management: antibiotics are the mainstay. The decision to intervene depends on rupture, hematoma or raised pressure, and whether the parent vessel supplies eloquent brain .
- Children with endocarditis (151): 2.6% developed infectious aneurysms. Ruptured ones rebled often, so early open or endovascular treatment should be considered .
- Traumatic pseudoaneurysms:
- Pooled data (87 children): occlusion 89.6% and favorable outcome 85.5%.
- Treating the aneurysm sac directly recurred more often than parent-vessel reconstruction or occlusion .
Genetics and syndromes
- Microcephalic osteodysplastic primordial dwarfism type II (MOPDII, PCNT):
- 64% of 47 registry patients had moyamoya, aneurysms or both. Moyamoya tended to appear younger than aneurysms .
- Proposed screening: MRI and MRA of the neck and head at diagnosis, then yearly until age 10 and every 2 years after, lifelong .
- Vascular Ehlers–Danlos syndrome (COL3A1, type III collagen):
- Fragile arteries lead to carotid–cavernous fistulas and circle of Willis aneurysms, and endovascular procedures carry higher risk .
- Across EDS subtypes: 165 of 720 reported aneurysms were intracranial. Multiple aneurysms were common, and rupture was sometimes the first sign of EDS .
- PHACE syndrome: all 7 children studied had cervical or cerebral arterial anomalies, including fusiform or berry aneurysms in 5. Image children with extensive facial hemangiomas .
- Other associations to consider: autosomal dominant polycystic kidney disease, connective tissue disorders (Marfan, Loeys–Dietz), sickle cell disease and HIV arteriopathy. These are listed as clinical associations and were not separately verified here.
Treatment and outcomes
- Clip or coil:
- Meta-analysis (560 children): endovascular and surgical treatment gave similar favorable outcomes (88.3% vs 82.7%) .
- Recurrence: in a 48-study review, mean recurrence was 12.7% after endovascular treatment vs 3.9% after surgery .
- One large center favors microsurgery for that reason (6.7% vs 0% recurrence in its series) .
- Outcomes:
- 85.1% had mRS 0–2, and mortality was 10.6%, all in children with SAH .
- Children 15 or younger: 68.6% favorable outcome despite 19.6% mortality. Early ischemia predicted a poor outcome, and size over 5 mm predicted recurrence .
Lifelong follow-up
- New and recurrent aneurysms accumulate:
- Over a median 34 years, 41% of patients treated in childhood developed de novo or recurrent aneurysms (1.9% per year), and 7 had new SAH.
- Smoking raised the risk (RR 2.44) .
- Recommended imaging :
- DSA right after treatment and at 6–12 months after endovascular treatment.
- CTA for long-term follow-up of clipped aneurysms.
- MRA for untreated, coiled or otherwise treated aneurysms.
- Annual rates after treatment: bleeding 1.4% and recurrence 2.6% in one series .
Related topics
- Giant Intracranial Aneurysms in Children: giant lesions in detail.
- Hereditary Vasculopathies: Loeys-Dietz, vascular EDS and Marfan.
- Moyamoya Disease and Syndrome: associated arteriopathy in MOPDII.
- Arterial Ischemic Stroke in Children: ischemic presentations of arteriopathy.
References
- Sousa MP, Ribeiro FV, Batista S, et al. Evaluating the efficacy and safety of flow diverter in pediatric cerebral aneurysm treatment: a systematic review and meta-analysis. J Clin Neurosci 2024;130:110909. doi:10.1016/j.jocn.2024.110909. PMID 39522305. verified
- Xu R, Xie ME, Yang W, et al. Epidemiology and outcomes of pediatric intracranial aneurysms: comparison with an adult population in a 30-year, prospective database. J Neurosurg Pediatr 2021;28(6):685–694. doi:10.3171/2021.6.PEDS21268. PMID 34507296. verified
- Huang J, McGirt MJ, Gailloud P, et al. Intracranial aneurysms in the pediatric population: case series and literature review. Surg Neurol 2005;63(5):424–432. doi:10.1016/j.surneu.2004.11.023. PMID 15883063. verified
- Ghali MGZ, Srinivasan VM, Cherian J, et al. Pediatric intracranial aneurysms: considerations and recommendations for follow-up imaging. World Neurosurg 2018;109:418–431. doi:10.1016/j.wneu.2017.09.150. PMID 28986225. verified
- Cherian J, Srinivasan V, Froehler MT, et al. Flow diversion for treatment of intracranial aneurysms in pediatric patients: multicenter case series. Neurosurgery 2020;87(1):53–62. doi:10.1093/neuros/nyz380. PMID 31557290. verified
- Pruvot AS, Curey S, Derrey S, et al. Giant intracranial aneurysms in the paediatric population: suggested management and a review of the literature. Neurochirurgie 2016;62(1):20–24. doi:10.1016/j.neuchi.2013.06.004. PMID 24210289. verified
- Fry L, Brake A, Heskett CA, et al. Endovascular management of pediatric traumatic intracranial pseudoaneurysms: a systematic review and case series. World Neurosurg 2023;176:213–226. doi:10.1016/j.wneu.2023.04.028. PMID 37059359. verified
- Flores BC, Patel AR, Braga BP, et al. Management of infectious intracranial aneurysms in the pediatric population. Childs Nerv Syst 2016;32(7):1205–1217. doi:10.1007/s00381-016-3101-7. PMID 27179531. verified
- Giraudo F, El Baba B, Alawieh AM, et al. Incidence, management, and outcomes of pediatric infectious aneurysms. Oper Neurosurg 2024;29(1):27–33. doi:10.1227/ons.0000000000001391. PMID 39412344. verified
- Duker AL, Kinderman D, Jordan C, et al. Microcephalic osteodysplastic primordial dwarfism type II is associated with global vascular disease. Orphanet J Rare Dis 2021;16(1):231. doi:10.1186/s13023-021-01852-y. PMID 34016138. verified
- Perry LD, Robertson F, Ganesan V. Screening for cerebrovascular disease in microcephalic osteodysplastic primordial dwarfism type II (MOPD II): an evidence-based proposal. Pediatr Neurol 2013;48(4):294–298. doi:10.1016/j.pediatrneurol.2012.12.010. PMID 23498563. verified
- Olubajo F, Kaliaperumal C, Choudhari KA. Vascular Ehlers-Danlos syndrome: literature review and surgical management of intracranial vascular complications. Clin Neurol Neurosurg 2020;193:105775. doi:10.1016/j.clineuro.2020.105775. PMID 32197145. verified
- Shabani M, Abdollahi A, Brar BK, et al. Vascular aneurysms in Ehlers-Danlos syndrome subtypes: a systematic review. Clin Genet 2023;103(3):261–267. doi:10.1111/cge.14245. PMID 36210598. verified
- Luo CB, Lasjaunias P, Teng MM, et al. Cervico-cerebrovascular anomalies in children with PHACE syndrome. J Formos Med Assoc 2003;102(6):379–386. PMID 12923590. (verified; no DOI listed on PubMed)
- Yasin JT, Wallace AN, Madaelil TP, et al. Treatment of pediatric intracranial aneurysms: case series and meta-analysis. J Neurointerv Surg 2019;11(3):257–264. doi:10.1136/neurintsurg-2018-014001. PMID 30100557. verified
- Brandel MG, Plonsker JH, Rennert RC, et al. Treatment of pediatric intracranial aneurysms: institutional case series and systematic literature review. Childs Nerv Syst 2024;40(8):2419–2429. doi:10.1007/s00381-024-06384-x. PMID 38635071. verified
- Amelot A, Saliou G, Benichi S, et al. Long-term outcomes of cerebral aneurysms in children. Pediatrics 2019;143(6):e20183036. doi:10.1542/peds.2018-3036. PMID 31068385. verified
- Koroknay-Pál P, Niemelä M, Lehto H, et al. De novo and recurrent aneurysms in pediatric patients with cerebral aneurysms. Stroke 2013;44(5):1436–1439. doi:10.1161/STROKEAHA.111.676601. PMID 23463758. verified
Verification (2026-11-03): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed, and every figure cited was checked against the PubMed abstract. Full texts were not reviewed. Reference 17's article number (e20183036) is taken from its DOI because PubMed lists no page. The COL3A1 gene name for vascular EDS is standard; reference 12 says "the gene that encodes type III collagen." The "other associations" (ADPKD, Marfan, Loeys–Dietz, sickle cell, HIV) are listed as clinical associations without verified sources; the KDIGO 2025 ADPKD guideline abstract was reviewed but gave no aneurysm specifics. The treatment options for fusiform and dissecting aneurysms (reconstruction, occlusion, bypass and trapping) summarize references 5 and 7 and standard practice. The schematic is an original figure.